Ivan Brana

Dr. Ivan Brana is a phase I and precision oncology specialist at Vall d'Hebron's VHIO with expertise in basket trials targeting rare molecular alterations. He has led studies on AKT1 E17K inhibition, NRG1 fusion-directed therapy, and uncommon EGFR mutations across multiple tumor types. His work represents the frontier of precision oncology molecular tumor board practice where rare variants can be matched to investigational therapies.